首页> 美国卫生研究院文献>Case Reports in Oncology >Well-Differentiated Grade 2 Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case
【2h】

Well-Differentiated Grade 2 Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case

机译:分化程度高的2级3型胃肠道神经内分泌肿瘤伴有双侧转移性卵巢侵犯:一例罕见病例的报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Treatment of metastatic gastric neuroendocrine tumours (NETs) is challenging. In oligometastatic cases, surgical resection is recommended whenever possible. Somatostatin analogues have been used to decrease gastrin levels, and available evidence suggests that these drugs can also reduce recurrences. Here we present a highly unusual case involving a patient with a well-differentiated grade 2, type 3 gastric NET with exclusive metastatic bilateral ovarian involvement. To our knowledge, this is the first such case reported in the literature, as the cause of ovarian involvement is usually due to local invasion rather than metastasis. We believe this case is of interest not only due to the unusual presentation, but also because it makes us consider adjuvant treatment with somatostatin analogues in patients with low-grade tumours and a positive postoperative octreoscan.
机译:转移性胃神经内分泌肿瘤(NETs)的治疗具有挑战性。在低转移病例中,建议尽可能手术切除。生长抑素类似物已被用于降低胃泌素水平,现有证据表明这些药物也可以减少复发。在这里,我们介绍了一个高度不寻常的病例,该病例涉及一个分化良好的2级,3型胃网,仅转移性双侧卵巢受累的患者。据我们所知,这是文献报道的首例此类病例,因为卵巢受累的原因通常是由于局部浸润而不是转移引起的。我们认为该病例不仅因为异常的表现而引起人们的关注,而且因为它使我们考虑对生长激素抑制素类似物在低度肿瘤和术后奥曲扫描阳性的患者进行辅助治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号